Firm-fixed price purchase of one promethion 2 integrated (P2I) long-read sequencing platform, including installation, calibration, standard support plan, and initial user training. The P2I provides…
Active Purchase Order Awarded
- Contract number
- 140D0426P0257
- Awardee
-
Oxford Nanopore Technologies, Inc. UEI FM6MMNBM2TQ5
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $66,380
Award facts
- Opportunity
-
- Presolicitation notice (sole source) for acquisit Solicitation · 140D0426Q0870 · Posted Aug 26, 2026
- Contract value 100% obligated
- $66,380.00 Current and potential, with all options
- Completion date 42% complete
- Current and potential, with all options
- Funding agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Oxford Nanopore Technologies, Inc., for one PromethION 2 Integrated long-read sequencing platform, including installation, calibration, standard support plan, and initial user training, valued at $66,380 and issued on September 24, 2026. No set-aside was used. Performance occurs at Bethesda, Maryland, with delivery and installation required within four to twelve weeks of award. The procurement originated from a Department of the Interior Interior Business Center competitive RFQ issued August 26, 2026, with quotations due September 2, 2026. The solicitation applied a Women-Owned Small Business set-aside, though the award carries no set-aside designation. Brand-name justification restricted competition to Oxford Nanopore based on compatibility with the CCR Genomics Core's existing validated workflows, flow cells, chemistries, and software pipelines; market research confirmed no alternative sequencing platform provides equivalent integrated compute capability while maintaining existing laboratory infrastructure. Contract completion is due January 23, 2027.
Description
Firm-fixed price purchase of one promethion 2 integrated (P2I) long-read sequencing platform, including installation, calibration, standard support plan, and initial user training. The P2I provides integrated CPU/GPU accelerated compute for real-time
Quick answers
Who was awarded contract 140D0426P0257?
140D0426P0257 was awarded to Oxford Nanopore Technologies, Inc. by Interior Business Center (Office of Policy Management and Budget) on September 24, 2026.
How much is contract 140D0426P0257 worth?
The government has obligated $66,380 on 140D0426P0257.
Which agency awarded contract 140D0426P0257?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0426P0257, with funding from National Cancer Institute (National Institutes of Health).
Was contract 140D0426P0257 competed?
The extent of competition for 140D0426P0257 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award